A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

Recruiting

Phase 3

MACI vs. Bone Marrow StimulationA Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

Sponsor:

Vericel Corporation

Code:

NCT06915233

Conditions

Chondral Defect

Articular Cartilage Defect

Eligibility Criteria

Sex: All

Age: 17 - 65

Healthy Volunteers: Not accepted

Interventions

autologous cultured chondrocytes on porcine collagen membrane

Bone Marrow Stimulation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-09. This information was provided to ClinicalTrials.gov by Vericel Corporation on 2025-12-18.